Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 59 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
IMMO-PHARM from Etterbeek, company number BE0726954523, closed financial year 2025 with a result of € 16,580 after tax. For that financial year IMMO-PHARM recorded a gross margin of € 37,985 and equity of € 102,580. Compared with financial year 2024, the result moved from € 6,715 to € 16,580. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 102,580
▲ € 116,580 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16,580
▲ 147% vs 2024
Profit after tax over the fiscal year.
€ 11,530
▲ € 9,202 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -27,420.
Debts at end 2025
€ 381,507
▼ 5% vs 2024
€ 26,415 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 6,890
▼ 32% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 30,404 | € 34,905 | € 24,868 | € 37,985 | ▲ 53% |
| Profit after taxes | € 11,387 | € 16,313 | € 6,715 | € 16,580 | ▲ 147% |
| Equity | € -37,027 | € -20,715 | € -14,000 | € 102,580 | ▲ € 116,580 |
| Total debts | € 454,664 | € 433,647 | € 414,195 | € 395,665 | ▼ 4% |
| Cash | € 2,489 | € 6,986 | € 2,327 | € 11,530 | ▲ € 9,202 |
| Land & buildings | € 409,095 | € 398,869 | € 388,642 | € 474,716 | ▲ 22% |
| Retained profit | € -67,027 | € -50,715 | € -44,000 | € -27,420 | ▲ € 16,580 |
| Bank debt | € 449,996 | € 426,938 | € 403,440 | € 381,507 | ▼ 5% |
| Balance sheet total | € 417,636 | € 412,932 | € 400,196 | € 498,245 | ▲ 25% |
Key figures of IMMO-PHARM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to IMMO-PHARM?
What happened at IMMO-PHARM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 16,580 (▲ 147% vs 2024). Source: NBB ↗
- CHRIQTOPHE GUYOT became a director. NBB
- New establishment in Etterbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 11,387 profit in 2022 to € 16,580 profit in 2025.
Best year ever: 2025, with € 16,580 profit.
A new publication or filing at IMMO-PHARM? We notify you, reason included.
Follow IMMO-PHARMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
CHRIQTOPHE GUYOT
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Sint-Pietersplein 29 box 1
1040 Etterbeek
Sint-Pietersplein 29 box 4
1040 Etterbeek
Active since 21 May 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →ASSOCIATION DES COPROPRIETAIRES DE L'IMMEUBLE SIS à 1040 ETTERBEEK, PLACE SAINT-PIERRE 29
MY EXPRESS
€ 2.1 million revenue · 2025
Kesan Food
MEDITRINE
€ 145,949 gross margin · 2025
BLUE ADVICE & SERVICES
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0726.954.523
- VAT number
- BE 0726.954.523
- Registered office
- Sint-Pietersplein 29 bus 1, 1040 Etterbeek
- Names & denominations
- IMMO-PHARM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 May 2019
- Peppol
- Active · Active since 9 Oct 2025
- Contact
- [email protected] +32496877053